Results 111 to 120 of about 2,652 (202)

Ebola virus disease. [PDF]

, 2014
Beeching, Nicholas J, Fenech, Manuel, Houlihan, Catherine F   +2 more
core   +3 more sources

Medicine 2.0: Have We Gone Too Far? [PDF]

, 2017
Montanio, Alexandria K
core  

POSSIBILITIES OF PREVENTION AND TREATMENT OF HUMAN CYTOMEGALOVIRUS INFECTIONS INCLUDING NEW DRUGS AND COMPOUNDS WITH POTENTIAL APPLICATION [PDF]

, 2019
Majewska, Anna, Majewski, Sławomir, Malejczyk, Magdalena, Młynarczyk, Grażyna, Młynarczyk-Bonikowska, Beata   +4 more
core   +1 more source

King Kong Pox: A Case of Severe Mpox and Bartonella Co-infection in a Patient Living With Human Immunodeficiency Virus (HIV). [PDF]

Cureus
Karki A, Acharya A, Shrestha S, Thapa P, Pandey Y, Conti R, Lim L.   +6 more
europepmc   +1 more source

Broad-spectrum antiviral brincidofovir inhibits Epstein-Barr virus and related gammaherpesvirus in human and nonhuman primate cells. [PDF]

J Clin Invest
Donaldson A, Druker MR, Monaco MC, Stack EH, Zimmerman P, Lee A, Bialuk I, Frazier W, Cortese I, Narver H, Hazama M, Yoshida F, Li X, Krug LT, Piotrowski SL, Jacobson S.   +15 more
europepmc   +1 more source

The 2014–2015 Ebola outbreak in West Africa: Hands On [PDF]

core   +1 more source

Mechanism of Adenovirus C Resistance to Brincidofovir

, 2017
Human adenoviruses (HAdV) are responsible for significant morbidity and mortality in hematopoietic stem cell (HSC) recipients, particularly in children.Brincidofovir (BCV) prodrug of cidofovir is an analogue of cytosine. It inhibits the DNA polymerase (DNA pol) activity of HAdV by stopping elongation and competition with natural nucleotides.The ...
openaire   +1 more source

Evaluating the advancements and efficacies in pharmacological Mpox treatments: a comprehensive review. [PDF]

Front Pharmacol
Hudu SA, Saadi N, Tahir A, Jimoh AO, Haruna A.   +4 more
europepmc   +1 more source

Adeno-Where: A Case of Disseminated Adenovirus in a Transplant Patient [PDF]

, 2021
Bryan, Karen, Kathuria-Prakash, Nikhita, Kaushal, Khushboo   +2 more
core  

Mpox: disease manifestations and therapeutic development. [PDF]

J Virol
Wang Y, Wang X, Doğan T, Sam-Agudu NA, Al-Tawfiq JA, Pan Q.   +5 more
europepmc   +1 more source